SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

SCLN 8.96 -0.13 (-1.43%)
price chart
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)'s Insider Friedhelm Blobel ...
The President & CEO of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 8.96 -0.13 -1.43% , Friedhelm Blobel has made an unexpected deal in the -listed company that is having a value of $90,667 U.S.
SciClone Pharmaceuticals CEO Sells $90700.00 in Stock (SCLN)  sleekmoney
Friedhelm Blobel Sells 10000 Shares of SciClone Pharmaceuticals Stock (SCLN)  WKRB News
Why SciClone Pharmaceuticals, Inc. Is Surging Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Notable 52-Week Highs and Lows 3/12: (AMRN) (DG) (SCLN) High; (PQ) (CNX ...  StreetInsider.com
Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...  Benzinga
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results ...
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results - Earnings Call Transcript. | Nov. 10, 2014 9:47 PM ET | About: SciClone Pharmaceuticals, Inc. (SCLN) by: SA Transcripts. SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN).
Related articles »  
SciClone Pharmaceuticals, Inc. Discloses Insider Transaction
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN),The Officer (CFO & Senior VP, Finance) of SCICLONE PHARMACEUTICALS INC, Cheung Wilson Wai-Shun sold 7,803 shares at $9.07 on March 12, 2015. The Insider selling transaction had a total value ...
SciClone Pharmaceuticals Inc. (SCLN) is Trading Lower on Unusual Volume for ...
SciClone Pharmaceuticals Inc. (SCLN) experienced unusually high volume on Apr. 02, as the stock lost 3.34% to a closing price of $8.97.
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)'s President & CEO Friedhelm ...
The President & CEO of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 8.99 +0.04 0.45% and corporation's insider Friedhelm Blobel made a sale of 10,000 shares of the company based on the average share price of $9.1 of a share.
Update: Short Interest of SciClone Pharmaceuticals, Inc. Increases by 0.1%  Trade Journo
SciClone Pharmaceuticals CEO Friedhelm Blobel Sells 10000 Shares (SCLN)  sleekmoney
Buy, Sell, or Hold: SciClone Pharmaceuticals Inc. (NASDAQ:SCLN)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) develops and commercializes novel medicines for treating a broad range of the world's most serious diseases.
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q4 2014 Results ...
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q4 2014 Results - Earnings Call Transcript. Mar. 11, 2015 9:10 PM ET | About: SciClone Pharmaceuticals, Inc. (SCLN) by: SA Transcripts. SciClone Pharmaceuticals (NASDAQ:SCLN). Q4 2014 ...
SciClone Reports 2014 Financial Results and 2015 Outlook  Marketwired (press release)
SciClone Pharmaceuticals Stock Downgraded (SCLN)
SCICLONE PHARMACEUTICALS INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
SciClone Pharmaceuticals: Promising Biotech With China Exposure
SciClone Pharmaceuticals (NASDAQ:SCLN) is a $271.89 million small-cap biotech company based in the United States, but primarily focused on selling drugs in China.
Related articles »